Qantas (ASX:QAN) jumps on solid profit upgrade for 1HY23

Marc Kennis Marc Kennis, November 23, 2022

Qantas (ASX:QAN) upgraded it’s profit guidance for the first half of FY23 this morning

The company cited strong domestic consumer demand as international capacity remains restricted. So, instead of travelling abroad, Australians are spending more time and money in Australia.

Fuel prices are still at high levels, though, with Qantas expected to spend $5bn of jet fuel this year, a company record. Still, it expects underlying profit before tax to end up $150m higher, at $1.35bn to $1.45nm, than it expected just 6 weeks ago.

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

 

Qantas is a former Stocks Down Under Concierge stock that we made good money on for our subscribers. And it continues to perform with the share price up more than 5% today!

We believe this morning’s news also bodes well for a few of our current Concierge picks in the travel space. Check out Concierge today and get a FREE TRIAL now!

 

Qantas

QANTAS chart, log scale (Source: Tradingview)

 

 

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

No credit card needed and the trial expires automatically.

 

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Findi (ASX:FND): Its quadrupled in 12 months off the back of financial services in India

Until Findi (ASX:FND) came along, there were practically no ASX companies making money from India (or at least not many…

ASX Listing Rules

Here are 5 key ASX Listing Rules that investors need to know about!

All companies listed on the ASX need to know about the ASX Listing Rules. The reason is obvious: Because there’s…

ASX stocks fighting diabetes

Here are 3 ASX stocks fighting diabetes and the opportunity ahead of them

There aren’t many ASX stocks fighting diabetes, but the few that are have a big market opportunity ahead of them. And…